Meera Narasimhan to Piperazines
This is a "connection" page, showing publications Meera Narasimhan has written about Piperazines.
Connection Strength
0.113
-
A 13-week, randomized double-blind, placebo-controlled, cross-over trial of ziprasidone in bipolar spectrum disorder. J Clin Psychopharmacol. 2015 Jun; 35(3):319-23.
Score: 0.113